Search Results - "Gaydukova, I Z"

Comorbidities in inflammatory joint and spine diseases in XXI century by Gaydukova, I Z, Akulova, A I, Rebrov, A P

“…The evaluation the occurrence of comorbidities in patients with inflammatory diseases of the spine and joints and the assessment of the general changes in…”
Get full text

Efficiency and safety of different etoricoxib regimens in patients with axial spondyloarthritis, including ankylosing spondylitis by Gaydukova, I Z, Rebrov, A P

“…To study the clinical and laboratory efficiency and safety of different etoricoxib (ET) regimens in patients with axial spondyloarthritis (axSpA), including…”
Get full text

Stable high interleukin-17A concentration in patients with ankylosing spondylitis treated with tumor necrosis factor-α inhibitors during a year by I Z Gaydukova, A P Rebrov, A V Aparkina, E V Khondkaryan

“…Aim. To assess changes in the concentration of interleukin-17A (IL-17A) in patients with ankylosing spondylitis (AS) treated with tumor necrosis factor-α…”
Get full text

Anti-Inflammatory Treatment in Chronic Back Pain by Gaydukova, I. Z., Bichurina, D. M., Popova, Yu. R., Rebrov, A. P.

“…Objectives. To analyze the causes of the non-use of nonsteroidal anti-inflammatories (NSAID) and discontinuation of previously used NSAID treatment in patients…”
Get full text

Spondyloarthritis: modern terminology and definitions by Erdes, Sh F, Rebrov, A P, Dubinina, T V, Badokin, V V, Bochkova, A G, Bugrova, O V, Gaydukova, I Z, Godzenko, A A, Dubikov, A A, Ivanova, O N, Korotaeva, T V, Lapshina, S A, Nesmeyanova, O B, Nikishina, I P, Otteva, E N, Raskina, T A, Rumyantseva, O A, Sitalo, A V, Smirnov, A V

“…Aim to identify outdated terms and make changes to the terminology of spondyloarthritis. Materials and methods. At the first stage of the work, the terms…”
Get full text

Efficacy and safety of intravenous methylprednisolone in the treatment of patients with active ankylosing spondylitis: results of a 12-week, prospective, open-label, pilot (METALL) study by Gaydukova, I Z, Rebrov, A P, Poddubnyi, D A

“…To evaluate the efficacy and safety of intravenous methylprednisolone (MP) 500 mg in patients with active ankylosing spondylitis (AS) and the inefficiency,…”
Get full text

Comparative pharmacoeconomic effectiveness of interleukin-17 inhibitors for the treatment of ankylosing spondylitis by Dubinina, T. V., Gaydukova, I. Z., Sableva, N. А., Sapozhnikov, K. V., Sokolova, V. D., Tolkacheva, D. G.

“…Objective – to compare the clinical efficacy and cost-effectiveness of IL-17 inhibitors (SEC, IXE, NTK) in the treatment of adult patients with ankylosing…”
Get full text

Real-World Retention Rate, Effectiveness, and Safety of Netakimab in the Treatment of Patients with Ankylosing Spondylitis: First Year Results of the LIBRA Post-Registration Safety Study by Erdes, Sh, Mazurov, V. I., Gaydukova, I. Z., Anoshenkova, O. N., Vinogradova, I. B., Grabovetskaya, Yu. Yu, Davidian, S. Y., Kiryukhina, N. A., Epifanova, O. E., Masneva, L. V., Menshikova, L. V., Mironenko, O. N., Nikulenkova, N. E., Povarova, T. V., Poliatika, A. N., Samigullina, R. R., Sizikov, A. E., Totrov, I. N., Umnova, I. F., Usacheva, J. V., Chudinov, A. L.

“…—Background. Netakimab has shown high efficacy in controlled clinical trials in the treatment of AS patients. This article presents results of an observational…”
Get full text

Etanercept in axial spondyloarthritis – treatment efficacy by Gaydukova, I. Z., Inamova, O. V., Samigullina, R. R., Chudinov, A. L., Bychkova, A. S.

“…The beginning of the 21st century was marked by a simultaneous changes in view on pathogenesis, diagnostics and treatment of axial spondyloarthritis (axSpA)…”
Get full text

Main circulating CD8+ T cell subsets in patients with systemic lupus erythematosus by Benevolenskaya, S. S., Kudriavtsev, I. V., Serebriakova, M. K., Rubinstein, A. A., Kuvardin, E. S., Grigor’yeva, I. N., Aliev, D. B., Zammoeva, D. B., Motorin, D. B., Golovkin, A. S., Kalinina, O. V., Lapin, S. V., Gaydukova, I. Z., Maslyanskiy, A. L., Gaydukova, E. K.

“…Relevance . Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by loss of immune tolerance and sustained production of autoantibodies…”
Get full text

The Level of IgA Antibodies to CD74 in Patients with Spondyloarthritis and Degenerative-Dystrophic Diseases of the Spine by Rebrov, A. P., Gaydukova, I. Z., Aparkina, A. V., Korolev, M. A., Safarova, K. N., Dorogoikina, K. D., Bichurina, D. M.

“…Background. According to the scientific literature, anti-CD74 IgA antibodies (IgA anti-CD74) are considered as a possible marker for the diagnosis of axial…”
Get full text

Long-term efficacy and safety of netakimab in patients with active ankylosing spondylitis: results of three years of use in the international multicentre, randomized, double-blind, phase III clinical trial BCD-085-5/ASTERA by Mazurov, V. I., Erdes, Sh. F., Gaydukova, I. Z., Dubinina, T. V., Pristrom, A. M., Kunder, E. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Zhugrova, E. S., Plaksina, T. V., Shesternya, P. A., Kropotina, T. V., Antipova, O. V., Smolyarchuk, E. A., Tsyupa, O. A., Abdulganieva, D. I., Lapshina, S. A., Krechikova, D. G., Gordeev, I. G., Nesmeyanova, O. B., Ilivanova, E. P., Strelkova, A. V., Tyrenko, V. V., Mikhailova, E. A., Eremeeva, A. V.

“…The article presents the results of the three-year use of netakimab (NTK) in patients with ankylosing spondylitis (AS) as part of the phase III…”
Get full text

Real-world retention rate, effectiveness, and safety of netakimab in the treatment of patients with ankylosing spondylitis: First year results of the LIBRA post-registration safety study by Erdes, Sh, Mazurov, V. I., Gaydukova, I. Z., Anoshenkova, O. N., Vinogradova, I. B., Grabovetskaya, Yu. Yu, Davidian, S. Yu, Epifanova, O. E., Kiryukhina, N. A., Masneva, L. V., Menshikova, I. V., Mironenko, O. N., Nikulenkova, N. E., Povarova, T. V., Polyatika, A. N., Samigullina, R. R., Sizikov, A. E., Totrov, I. N., Umnova, I. F., Usacheva, J. V., Chudinov, A. L.

“…Background . Netakimab has shown high efficacy in controlled clinical trials in the treatment of patients with ankylosing spondylitis (AS). This article…”
Get full text

Long-term effects of netakimab on health-related quality of life, back pain and work productivity in patients with ankylosing spondylitis: results of the international, multicentre, randomized double-blind phase III clinical trial BCD-085-5/ASTERA by Dubinina, T. V., Demina, A. B., Agafonova, E. M., Erdes, Sh. F., Mazurov, V. I., Gaydukova, I. Z., Pristrom, A. M., Kunder, E. V., Soroka, N. F., Kastanayan, A. A., Povarova, T. V., Zhugrova, E. S., Plaksina, T. V., Shesternya, P. A., Kropotina, T. V., Antipova, O. V., Smolyarchuk, E. A., Tsyupa, O. A., Abdulganieva, D. I., Lapshina, S. A., Krechikova, D. G., Gordeev, I. G., Nesmeyanova, O. B., Tyrenko, V. V., Ilivanova, E. P., Strelkova, A. V.

“…The article contains the data obtained during the 156-week follow-up of patients with ankylosing spondylitis (AS) in the ASTERA phase III study. Objective : to…”
Get full text

Efficacy and safety of biologics for the treatment of ankylosing spondylitis: systematic literature review and network meta-analysis of treatments registered in the Russian Federation by Dubinina, T. V., Gaydukova, I. Z., Sokolova, V. D., Mladov, V. V., Tolkacheva, D. G.

“…The aim of the study was to evaluate the comparative efficacy and safety of biologics registered and reimbursed in the Russian healthcare system for the…”
Get full text

Anti-CD74 IGA antibodies, genetic polymorphisms and inflammatory activity in ankylosing spondylitis by Mazurov, V. I., Gaydukova, I. Z., Vasilenko, E. A., Vasilenko, E. A., Lapin, S. V., Lapin, S. V., Kholopova, I. V., Korolev, M. A.

“…IgA anti-CD74 can be a promising marker for diagnosis, assessment of activity and prognosis for ankylosing spondylitis.The aim of the study was to determine…”
Get full text

Quality of life in spondyloarthritis patients receiving biological therapy by Akulova, A. I., Dorogoikina, K. D., Gaydukova, I. Z., Rebrov, A. P.

“…Spondyloarthritides (SpAs) is a group of chronic inflammatory diseases of the spine, joints, and entheses characterized by common clinical, radiological, and…”
Get full text

Effectiveness and safety of BCD180, anti-TRBV9+ T-lymphocytes monoclonal antibody in patients with active radiographic axial spondyloarthritis: 36-week results of double-blind randomized placebo-controlled phase II clinical study ELEFTA by Nasonov , E. L., Mazurov, V. I., Lila, A. M., Dubinina, T. V., Gaydukova, I. Z., Lapshina, S. A., Klimenko, A. A., Somov, D. V., Lukianov, S. A., Chudakov, D. M., Zvyagin, I. V., Britanova, O. V., Korolev, M. A., Abdulganieva, D. I., Krechikova, D. G., Kastanayan, A. A., Eliseeva, L. V., Samigullina, R. R., Povarova, T. V., Antipova, O. V., Smakotina, S. A., Soboleva, V. N., Nesmeyanova, O. B., Plaksina, T. V., Soroka, N. F., Vinogradova, I. B., Rebrov, A. P., Kropotina, T. V., Maslyanskiy, A. L., Zinkina-Orikhan, A. V., Lin’kova, Yu. N., Pukhtinskaia, P. S., Morozova, M. A., Vinderskaya, G. A.

“…The aim – to evaluate the clinical effectiveness, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of seniprutug (BCD-180) in patients with…”
Get full text

Validation of the Russian-language version of the ASAS Health Index by Akulova, A. I., Rebrov, A. P., Erdes, Sh, Gaydukova, I. Z.

“…The Assessment of Spondyloarthritis International Society (ASAS) Health Index (HI) is a comprehensive tool for quantifying the health of patients with axial…”
Get full text

VALIDATION OF THE EQ-5D-5L VERSION IN RUSSIA by Akulova, A. I, Gaydukova, I. Z., Rebrov, A. P.

“…The paper discusses the process for validation of the Russian-language EQ-5D-5L version to assess quality of life. According to international and national…”
Get full text